Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia
about
Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia
description
im April 2016 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2016
@uk
name
Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia
@en
Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia
@nl
type
label
Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia
@en
Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia
@nl
prefLabel
Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia
@en
Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia
@nl
P2860
P1476
Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia
@en
P2093
Wilma Barcellini
P2860
P2888
P304
P356
10.1007/S10875-016-0282-5
P577
2016-04-12T00:00:00Z